Cargando…

How to deprescribe esketamine in resistant depression? A point of view after first clinical uses

Detalles Bibliográficos
Autores principales: Taillefer de Laportalière, T., Yrondi, A., Jullien, A., Cestac, P., Montastruc, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786612/
https://www.ncbi.nlm.nih.gov/pubmed/35012701
http://dx.doi.org/10.1017/S204579602100072X
_version_ 1784639149380206592
author Taillefer de Laportalière, T.
Yrondi, A.
Jullien, A.
Cestac, P.
Montastruc, F.
author_facet Taillefer de Laportalière, T.
Yrondi, A.
Jullien, A.
Cestac, P.
Montastruc, F.
author_sort Taillefer de Laportalière, T.
collection PubMed
description
format Online
Article
Text
id pubmed-8786612
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-87866122022-02-08 How to deprescribe esketamine in resistant depression? A point of view after first clinical uses Taillefer de Laportalière, T. Yrondi, A. Jullien, A. Cestac, P. Montastruc, F. Epidemiol Psychiatr Sci Letter to the Editor Cambridge University Press 2022-01-11 /pmc/articles/PMC8786612/ /pubmed/35012701 http://dx.doi.org/10.1017/S204579602100072X Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
spellingShingle Letter to the Editor
Taillefer de Laportalière, T.
Yrondi, A.
Jullien, A.
Cestac, P.
Montastruc, F.
How to deprescribe esketamine in resistant depression? A point of view after first clinical uses
title How to deprescribe esketamine in resistant depression? A point of view after first clinical uses
title_full How to deprescribe esketamine in resistant depression? A point of view after first clinical uses
title_fullStr How to deprescribe esketamine in resistant depression? A point of view after first clinical uses
title_full_unstemmed How to deprescribe esketamine in resistant depression? A point of view after first clinical uses
title_short How to deprescribe esketamine in resistant depression? A point of view after first clinical uses
title_sort how to deprescribe esketamine in resistant depression? a point of view after first clinical uses
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786612/
https://www.ncbi.nlm.nih.gov/pubmed/35012701
http://dx.doi.org/10.1017/S204579602100072X
work_keys_str_mv AT tailleferdelaportalieret howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses
AT yrondia howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses
AT julliena howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses
AT cestacp howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses
AT montastrucf howtodeprescribeesketamineinresistantdepressionapointofviewafterfirstclinicaluses